Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for Prophylaxis of Neonatal Jaundice
NCT06451900Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jul 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fenofibrate in jaundice (3 arms), sponsored by Ain Shams University. Primary endpoints: Change in Total Serum Bilirubin at 5 days, Start of Phototherapy at 5 days and 1 more. Started Jul 2023; status: completed.
02
Drugs
fenofibrate
03
Conditions
jaundice
Beyond the preview
Go deeper on NCT06451900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06451900.